As progressively smaller premature infants survive beyond the first few days of life, healthcare-associated infections (HAIs) have emerged as a major cause of morbidity and late mortality in the neonatal intensive care unit (NICU). Effective prevention and treatment of HAIs in the NICU require an understanding of the distribution of pathogens, the various patient-related risk factors for these infections, and the roles of medications and invasive procedures in predisposing to their occurrence. 